Thymosin alpha-1 has minimal effect on tumor cells but strongly activates CD8+ T cells for anti-cancer immunity
Thymosin alpha-1 showed minimal transcriptional immunomodulation on melanoma, glioblastoma, and mesothelioma cells but significantly affected immune cell subsets, with the greatest impact on activated CD8+ T cells crucial for anti-tumor immunity.
Quick Facts
What This Study Found
Cancer cells: minimal DEGs and immune-related changes after Tα1. Immune cells: significant transcriptional changes in all subsets. Greatest impact: activated CD8+ T cells. Tα1 directly affects immune cell proliferation and transcription.
Key Numbers
How They Did This
nCounter SPRINT Profiler gene expression analysis of melanoma, glioblastoma, mesothelioma cell lines and HD CD4+ T, CD8+ T, B, NK cells after 48h Tα1 treatment.
Why This Research Matters
Understanding that Tα1 works through immune activation rather than direct tumor modification is crucial for designing combination immunotherapy strategies—Tα1 should be paired with approaches that enhance tumor antigen presentation.
The Bigger Picture
This clarifies Tα1's role as an immune enhancer rather than a direct tumor modifier, guiding rational combination with checkpoint inhibitors, vaccines, or other immunotherapies.
What This Study Doesn't Tell Us
In vitro only. Gene expression may not reflect protein-level changes. Healthy donor immune cells may respond differently than cancer patient cells. Limited cancer types tested.
Questions This Raises
- ?Should Tα1 be combined with checkpoint inhibitors for optimal anti-tumor immunity?
- ?Does Tα1 activate tumor-infiltrating CD8+ T cells as effectively as peripheral ones?
- ?Would patient-derived immune cells show the same Tα1 response?
Trust & Context
- Key Stat:
- CD8+ T cells most responsive Thymosin alpha-1 had its greatest transcriptional impact on activated CD8+ T cells while barely affecting tumor cell immunogenicity
- Evidence Grade:
- In vitro transcriptomic study with appropriate controls. Good mechanistic insight but limited to gene expression.
- Study Age:
- Published in 2025.
- Original Title:
- The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell Subsets.
- Published In:
- OncoTargets and therapy, 18, 995-1012 (2025)
- Authors:
- Solmonese, Laura, Lofiego, Maria Fortunata, Fazio, Carolina, Marzani, Francesco, Piazzini, Francesca, Bello, Emma, Celesti, Fabrizio, Giacobini, Gianluca, Wang, Xiaohui, Maio, Michele, Coral, Sandra, Di Giacomo, Anna Maria, Covre, Alessia
- Database ID:
- RPEP-13641
Evidence Hierarchy
Frequently Asked Questions
Does thymosin alpha-1 directly fight cancer?
Not really. This study found Tα1 has minimal direct effects on cancer cells themselves. Instead, it powerfully activates immune cells—especially CD8+ T cells that kill cancer. This means Tα1's anti-cancer value is through boosting the immune system, not directly attacking tumors.
How should thymosin alpha-1 be used in cancer treatment?
Based on these findings, Tα1 should be combined with treatments that help the immune system recognize cancer cells (like vaccines or checkpoint inhibitors), since its main strength is supercharging immune cell activity rather than making tumors more visible to the immune system.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-13641APA
Solmonese, Laura; Lofiego, Maria Fortunata; Fazio, Carolina; Marzani, Francesco; Piazzini, Francesca; Bello, Emma; Celesti, Fabrizio; Giacobini, Gianluca; Wang, Xiaohui; Maio, Michele; Coral, Sandra; Di Giacomo, Anna Maria; Covre, Alessia. (2025). The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell Subsets.. OncoTargets and therapy, 18, 995-1012. https://doi.org/10.2147/OTT.S527785
MLA
Solmonese, Laura, et al. "The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell Subsets.." OncoTargets and therapy, 2025. https://doi.org/10.2147/OTT.S527785
RethinkPeptides
RethinkPeptides Research Database. "The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor C..." RPEP-13641. Retrieved from https://rethinkpeptides.com/research/solmonese-2025-the-immunomodulatory-activity-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.